Dermata Therapeutics Inc. (NASDAQ: DRMA)
$2.12
-0.0700 ( -3.20% ) 71.5K
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
Market Data
Open
$2.12
Previous close
$2.19
Volume
71.5K
Market cap
$1.39M
Day range
$1.90 - $2.24
52 week range
$1.90 - $24.60
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 44 | Nov 09, 2023 |
8-k | 8K-related | 18 | Nov 09, 2023 |
8-k | 8K-related | 16 | Aug 10, 2023 |
10-q | Quarterly Reports | 46 | Aug 10, 2023 |
8-k | 8K-related | 16 | Aug 03, 2023 |